Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 29073584

Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Eur J Cancer
Publication date
2017 Nov
First author
Basset-Séguin N

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Basset-Séguin N
      type
      Author
    2. name
      Hauschild A
      type
      Author
    3. name
      Kunstfeld R
      type
      Author
    4. name
      Grob J
      type
      Author
    5. name
      Dréno B
      type
      Author
    6. name
      Mortier L
      type
      Author
    7. name
      Ascierto PA
      type
      Author
    8. name
      Licitra L
      type
      Author
    9. name
      Dutriaux C
      type
      Author
    10. name
      Thomas L
      type
      Author
    11. name
      Meyer N
      type
      Author
    12. name
      Guillot B
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Basset-Séguin N
      type
      Author
    2. name
      Hauschild A
      type
      Author
    3. name
      Kunstfeld R
      type
      Author
    4. name
      Grob J
      type
      Author
    5. name
      Dréno B
      type
      Author
    6. name
      Mortier L
      type
      Author
    7. name
      Ascierto PA
      type
      Author
    8. name
      Licitra L
      type
      Author
    9. name
      Dutriaux C
      type
      Author
    10. name
      Thomas L
      type
      Author
    11. name
      Meyer N
      type
      Author
    12. name
      Guillot B
      type
      Author
    bibliography ids
    1. nci-bib-86c85c6f63996e3dce16c085
    book metadata
    content sha256
    cc7f06a7355bf0bdd07a9a6de40b6366713513c4ef84629b8f39192c38b59d3e
    document type
    citation
    dois
    1. 10.1016/j.ejca.2017.08.022
    electronic publication date
    display
    2017 Nov 5
    precision
    day
    year
    2017
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:29073584
    immutable id
    pubmed:29073584@cc7f06a7355bf0bdd07a9a6de40b6366713513c4ef84629b8f39192c38b59d3e
    journal
    abbreviation
    Eur J Cancer
    issn electronic
    1879-0852
    issn print
    0959-8049
    issue
    Source null
    name
    European journal of cancer (Oxford, England : 1990)
    nlm unique id
    9005373
    pages
    334-348
    volume
    86
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      29073584
      provenance
      batch id
      fb25b16edcb1373b70c1
      provider
      NCBI PubMed ESummary
      record sha256
      0325b341fbd40e0e4d9a1608538353032e0aacf1c9e2d91d95b66e62df1c295a
      response sha256
      182c99bf1974b58308315b66aa28d31c61e8fc31cf3de4cadb0340a4f6734c52
      retrieved at
      2026-09-09T23:47:28.490065+00:00
      publication date
      display
      2017 Nov
      precision
      month
      year
      2017
      publication types
      1. Clinical Trial
      2. Journal Article
      3. Multicenter Study
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/29073584/
      title
      Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trial.

      Preserved source evidence · Not medical advice